Evidence map›Paper›PMID 41351882›Full record

Observational studyUltrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology2026

First-trimester Placental Ultrasound (FirstPLUS) study: prediction of fetal growth restriction using OxNNet-derived first-trimester placental volume.

S Mathewlynn, L Nicolatino Starck, D Wright, Y Yin, M Soltaninejad, K H Nicolaides, A Syngelaki, A Galán Contreras, S Bigiotti, E-M Woess and 2 more

Abstract readObservational Study
In one paragraph

Observational study in Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

S Mathewlynn *Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.ORCID 0000-0003-1609-3654
L Nicolatino Starck *Fetal Medicine Research Institute, King's College Hospital, London, UK.ORCID 0009-0002-3564-9072
D WrightInstitute of Health Research, University of Exeter, Exeter, UK.
Y YinNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.ORCID 0000-0001-5821-7497
M SoltaninejadNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.ORCID 0000-0002-9889-4369
K H NicolaidesFetal Medicine Research Institute, King's College Hospital, London, UK.ORCID 0000-0003-1266-0711
A SyngelakiFetal Medicine Research Institute, King's College Hospital, London, UK.ORCID 0000-0001-5856-6072
A Galán ContrerasFetal Medicine Research Institute, King's College Hospital, London, UK.
S BigiottiFetal Medicine Research Institute, King's College Hospital, London, UK.
E-M WoessFetal Medicine Research Institute, King's College Hospital, London, UK.
M SwinburneNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.ORCID 0009-0000-3979-6761
S CollinsNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.ORCID 0000-0002-0648-7433

Funding

National Institue for Health Research AWARD02497NHSX AWARD02497
6 · The paper itself

Abstract

objectivesTo develop predictive models for fetal growth restriction (FGR) with and without the inclusion of OxNNet-derived first-trimester placental volume (FTPV), thereby evaluating the contribution of FTPV to these models and the extent to which FTPV percentile is associated with subsequent FGR.

methodsThis study utilized data from the First-trimester Placental Ultrasound (FirstPLUS) study, a longitudinal observational cohort study conducted at King's College Hospital NHS Foundation Trust, London, UK, between March and November 2022. Participants underwent routine ultrasound assessment between 11 + 2 and 14 + 1 weeks' gestation, in addition to three-dimensional placental sonography. The OxNNet toolkit was used for automated placental segmentation and volume calculation. Multivariable logistic regression models were developed to predict FGR, incorporating maternal factors, first-trimester biomarkers (serum pregnancy-associated plasma protein-A, mean arterial blood pressure and uterine artery pulsatility index) and FTPV.

resultsThe final cohort comprised 3500 pregnancies, of which 250 (7.1%) developed FGR. Low FTPV was found to be a risk factor for FGR, with an odds ratio of 1.736 (95% CI, 1.499-2.015) per unit decrease in FTPV Z-score. Incorporating FTPV into the predictive model based on maternal factors and biomarkers significantly increased the area under the receiver-operating-characteristics curve (AUC) for predicting all cases of FGR, from 0.78 (95% CI, 0.75-0.81) to 0.79 (95% CI, 0.76-0.82) (P = 0.005). Subgroup analysis of normotensive and hypertensive cases demonstrated a statistically significant effect size for the prediction of FGR by FTPV Z-score in both groups. The addition of FTPV to the model based on maternal factors and biomarkers for the prediction of normotensive FGR increased the AUC from 0.77 (95% CI, 0.74-0.80) to 0.78 (95% CI, 0.75-0.81) (P = 0.01). For preterm FGR, the AUC was 0.85 (95% CI, 0.78-0.92) with FTPV and 0.85 (95% CI, 0.79-0.92) without (P = 0.93); the absence of a significant difference may be due to a lack of power.

conclusionsFTPV Z-score is a predictor of FGR. Integrating FTPV into predictive models significantly enhanced the discriminative ability for all cases of FGR, as well as for the subgroup of normotensive FGR. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Indexed as

Fetal Growth RetardationPlacentaUltrasonography, PrenatalAdultBiomarkersFemaleGestational AgeHumansImaging, Three-DimensionalLondonLongitudinal StudiesOrgan SizePredictive Value of TestsPregnancyPregnancy-Associated Plasma Protein-APregnancy Trimester, FirstBiomarkersPregnancy-Associated Plasma Protein-Acrown–rump lengthfirst trimestergestational ageneural network (computer)placentareference valuesthree‐dimensional ultrasonographyvolume measurement

Identifiers

PMID41351882
PMCPMC12757825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.